文献速递慢性肾脏病

瑞典全国性研究:男女CKD进展与死亡差异

CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden.
PubMed 文献 · Am J Kidney Dis · 2021-01-09

该研究基于瑞典肾脏登记库2010至2018年未接受维持透析的CKD G3b-G5患者,采用竞争风险模型分析性别与CKD进展及死亡的关系。结果显示女性CKD进展风险、全因死亡和心血管死亡风险均低于男性,且男性eGFR下降更陡。

要点

  • 女性CKD进展风险低于男性(SHR 0.88)。
  • 女性全因死亡和心血管死亡风险均低于男性。
  • 男性eGFR下降速度更快,风险因素包括年龄、性别、白蛋白尿和原发病。

核心结论

  • 与女性相比,男性全因死亡和心血管死亡率更高,CKD进展风险更高,eGFR下降更陡。

研究设计与样本

  • 观察性队列研究,纳入瑞典全国肾脏登记库2010至2018年新发CKD G3b-G5成人患者。
  • 共纳入7388例G3b、18282例G4和9410例G5患者。

主要发现

  • 总体进展率为19.6例/100患者年(95%CI 19.2-20.0),死亡率为10.1例/100患者年(95%CI 9.9-10.3)。
  • 女性CKD进展风险较低(SHR 0.88,95%CI 0.85-0.92)。
  • 女性全因死亡风险较低(SHR 0.90,95%CI 0.85-0.94),心血管死亡风险较低(SHR 0.83,95%CI 0.76-0.90)。
  • eGFR下降更陡的相关风险因素包括年龄、性别、白蛋白尿和原发肾脏病类型。

临床怎么用

  • 临床中应关注男性CKD患者更高的进展和死亡风险,加强监测与干预。

局限性

  • 门诊就诊和实验室检查数据不完整,且存在报告的区域差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

RATIONALE & OBJECTIVE: Chronic kidney disease (CKD) is a global health problem with increasing prevalence. Several sex-specific differences have been reported for disease progression and mortality. Selection and survival bias might have influenced the results of previous cohort studies. The objective of this study was to investigate sex-specific differences of CKD progression and mortality among patients with CKD not receiving maintenance dialysis. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: Adult patients with incident CKD glomerular filtration rate categories 3b to 5 (G3b-G5) identified between 2010 and 2018 within the nationwide Swedish Renal Registry-CKD (SRR-CKD). EXPOSURE: Sex. OUTCOMES: Time to CKD progression (defined as a change of at least 1 CKD stage or initiation of kidney replacement therapy [KRT]) or death. Repeated assessments of estimated glomerular filtration rate (eGFR). ANALYTICAL APPROACH: CKD progression and mortality before KRT were assessed by the cumulative incidence function methods and Fine and Gray models, with death handled as a competing event. Sex differences in eGFR slope were estimated using mixed effects linear regression models. RESULTS: 7,388 patients with incident CKD G3b, 18,282 with incident CKD G4, and 9,410 with incident CKD G5 were identified. Overall, 19.6 (95% CI, 19.2-20.0) patients per 100 patient-years progressed, and 10.1 (95% CI, 9.9-10.3) patients per 100 person-years died. Women had a lower risk of CKD progression (subhazard ratio [SHR], 0.88 [95% CI, 0.85-0.92]), and a lower all-cause (SHR, 0.90 [95% CI, 0.85-0.94]) and cardiovascular (SHR, 0.83 [95% CI, 0.76-0.90]) mortality risk. Risk factors related to a steeper decline in eGFR included age, sex, albuminuria, and type of primary kidney disease. LIMITATIONS: Incomplete data for outpatient visits and laboratory measurements and regional differences in reporting. CONCLUSIONS: Compared to women, men had a higher rate of all-cause and cardiovascular mortality, an increased risk of CKD progression, and a steeper decline in eGFR.

来源:Am J Kidney Dis,查看原文。版权归原作者所有。

引用

  1. Swartling O, Rydell H, Stendahl M, et al. CKD Progression and Mortality Among Men and Women: A Nationwide Study in Sweden. Am J Kidney Dis. 2021. PMID: 33434591. doi:10.1053/j.ajkd.2020.11.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。